Zobrazeno 1 - 10 of 108 pro vyhledávání: '"D C Tormey"'
1
Phase II Trial of Carboplatin in Soft-Tissue Sarcoma
Autor: R. L. Comis, David Goldstein, D. C. Tormey, M. Shiraki, Ernest C Borden, J. E. Harris, B. Cheuvart, D. L. Trump
Publikováno v: American Journal of Clinical Oncology. 13:420-423
As part of the Eastern Cooperative Oncology Group program for the assessment of new drugs in sarcomas, a Phase II trial of carboplatin was performed in patients who had received no more than one prior chemotherapy regimen. A total of 50 patients rece
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0de31cc4e14e7477b9a0b2f13997f6
https://doi.org/10.1097/00000421-199010000-00011
Zobrazit plný text záznamu
3
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group
Autor: J E, Olson, D, Neuberg, K J, Pandya, M P, Richter, L J, Solin, K W, Gilchrist, D C, Tormey, M, Veeder, G, Falkson
Publikováno v: Cancer. 79(6)
The purpose of this study was to test the role of radiotherapy following total mastectomy, axillary dissection, and adjuvant systemic therapy in the management of operable locally advanced breast carcinoma.After undergoing mastectomy and axillary dis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9e89a12c189d60521f6b6a656b2f464e
https://pubmed.ncbi.nlm.nih.gov/9070481
Zobrazit plný text záznamu
4
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group
Autor: D C, Tormey, R, Gray, H C, Falkson
Publikováno v: Journal of the National Cancer Institute. 88(24)
Data from a pilot study published in 1984 suggested that tamoxifen administration (as adjuvant hormonal therapy) for more than 5 years after initial breast cancer surgery might have therapeutic benefit.A randomized trial was performed to assess the e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a4743127bd2a097019d951dd46c30fc1
https://pubmed.ncbi.nlm.nih.gov/8961967
Zobrazit plný text záznamu
5
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185)
Autor: C D, Cobau, K, Declercq, D, Neuberg, J N, Ingle, D C, Tormey
Publikováno v: Cancer. 77(3)
Human breast cancer cells in vitro exhibit increased levels of progestin receptors (PgR) after brief exposure to physiologic concentrations of estrogens. Prior clinical studies have positively correlated the responsiveness of metastatic breast cancer
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e0c291a6cdcb0c46193ded3e14196750
https://pubmed.ncbi.nlm.nih.gov/8630955
Zobrazit plný text záznamu
7
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen
Autor: K E, Gale, J W, Andersen, D C, Tormey, E G, Mansour, T E, Davis, J, Horton, J M, Wolter, T J, Smith, F J, Cummings
Publikováno v: Cancer. 73(2)
Tamoxifen and aminoglutethimide are two hormone therapies reported to be effective palliative approaches for patients with metastatic breast cancer. The current trial was designed to evaluate their relative therapeutic effectiveness.Two hundred forty
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f717ed74322c434ddf6e0f295207fe12
https://pubmed.ncbi.nlm.nih.gov/8293400
Zobrazit plný text záznamu
8
High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group)
Autor: K W, Gilchrist, R, Gray, A M, van Driel-Kulker, W E, Mesker, J J, Ploem-Zaaijer, J S, Ploem, S G, Taylor, D C, Tormey
Publikováno v: Breast cancer research and treatment. 28(1)
To investigate whether breast cancer cells with unusually high nuclear DNA content are associated with an adverse outcome, Eastern Cooperative Oncology Group investigators selected breast cancer trial patients who suffered an early death (ED) within
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::766ac96c3f882bc2f8a7ba359b2554e6
https://pubmed.ncbi.nlm.nih.gov/8123866
Zobrazit plný text záznamu
10
Phase II trials of interferons-alpha and -beta in advanced sarcomas
Autor: E C, Borden, K, Kim, L, Ryan, R H, Blum, M, Shiraki, D C, Tormey, R L, Comis, R G, Hahn, D R, Parkinson
Publikováno v: Journal of interferon research. 12(6)
Interferons (IFNs)-alpha and -beta were administered to patients with metastatic sarcomas in two different Eastern Cooperative Oncology Group studies. In one study, patients received IFN-alpha 2b, 20 million units/m2 i.v. 5 days/week x 4, then 10 mil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::68bf6191ed0ae90fd6efc1717e21d764
https://pubmed.ncbi.nlm.nih.gov/1289413
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje